1-13 of 13
contrast-enhanced magnetic resonance imaging
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Dose-Escalation Study of Thiotepa-Based Immunochemotherapy in Relapsed/Refractory Primary Central Nervous System Lymphoma; The Tier Trial

Christopher P Fox, MBChB(Hons), MRCP, FRCPath, PhD, Ayesha S Ali, MSc, Dorothee Auer, MD DM, PhD, Steffi Thust, MD FRCR, Aimee E Jackson, MSc, Louise Hopkins, BSc, MRes, Catherine Thomas, PhDBSc, Nicolas Martinez-Calle, MD MSc, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Shireen Kassam, MD, Josh Wright, MD, David Lewis, PhD FRCPath, BSc, Andres JM Ferreri, MD, Sridhar Chaganti, MDPhDMRCP,FRCPath, Jeffery Smith, MBChB BMedSci MRCP FRCPath, Kim Linton, MBChB PhD, Ian Chau, MD, Dominic J. Culligan, MD, Andrew Davies, MD PhD, Roderick Johnson, MD, Kate Cwynarski, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2879.
https://doi.org/10.1182/blood-2019-122830
Published: 2019
Journal Articles

Clinical Features, Diagnosis, and Prognosis of 22 Cases of Neurolymphomatosis : A Single-Institution Experience over 12 Years

Kentaro Narita, MD, Toshiki Terao, MD, Takafumi Tsushima, MD, Akihiro Kitadate, MD PhD, Daisuke Miura, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1630.
https://doi.org/10.1182/blood-2019-126706
Published: 2019
Journal Articles

Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma

Rudy Birsen, Estelle Blanc, MD, Barbara Burroni, MD, Chloe Broudin, MD, Lise Willems, MD, Marielle Legoff, MD, Emmanuelle Leray, MD, Sylvain Pilorge, MD, Sawsen Salah, MD, Aude Quentin, MD, Bénédicte Deau-Fisher, MD, Patricia Franchi, MD, Marguerite Vignon, MD, Laurence Mabille, MD, Charles Nguyen, MD, Youlia Kirova, MD, Pascale Varlet, MD, Arnault tauziede-Espariat, MD, Myriam Edjlali, MD, Dezamis Edouard, MD, Carole Soussain, MD PhD, Caroline Houillier, MD, Johan Pallud, MDPhD, Diane Damotte, MDPhD, Didier Bouscary, MDPhD, Jerome Tamburini Bonnefoy, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1573.
https://doi.org/10.1182/blood.V130.Suppl_1.1573.1573
Published: 2017
Journal Articles

Clinical Features, Diagnosis, and Prognosis of 14 Cases of Neurolymphomatosis: Single Institutional Experience over 10 Years

Yoshiaki Abe, MD, Yoshiaki Usui, MD, Kentaro Narita, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3042.
https://doi.org/10.1182/blood.V128.22.3042.3042
Published: 2016
Journal Articles

Prognostic Significance Of Parameters Of Dynamic Contrast-Enhanced MRI Detecting Increased Bone Marrow Microcirculation In Monoclonal Plasma Cell Disorders

Jens Hillengass, MD, Judith Ritsch, Maximilian Merz, MD, Hartmut Goldschmidt, MD, Christina Kunz, PhD, Barbara Wagner-Gund, Anthony Ho, MD, Thomas M. Moehler, MD, Stefan Delorme, MD
Journal: Blood
Blood (2013) 122 (21): 3146.
https://doi.org/10.1182/blood.V122.21.3146.3146
Published: 2013
Journal Articles

Anti-Vascular and Anti-Tumor Effects of the Vascular Disrupting Agent ASA404 (DMXAA) in Human Acute Leukemia Xenograft Models

Christopher W Schaefer, M.S., Deepika Lal, M.S., R Robert Vethanayagam, PhD, Joseph A Spernyak, PhD, Mukund Seshadri, PhD, Eunice S. Wang, MD
Journal: Blood
Blood (2011) 118 (21): 4293.
https://doi.org/10.1182/blood.V118.21.4293.4293
Published: 2011
Journal Articles

Prognostic Significance of the Number of Focal Lesions in Whole Body Magnetic Resonance Imaging Before and After Autologous Stem Cell Transplantation

Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, Marc André Weber, Thomas Hielscher, Hans-Ulrich Kauczor, Stefan Delorme, Anthony D. Ho, Hartmut Goldschmidt, Kai Neben, MD
Journal: Blood
Blood (2011) 118 (21): 1812.
https://doi.org/10.1182/blood.V118.21.1812.1812
Published: 2011
Journal Articles

Correlation of Serological and MRI-Based Treatment Response to Systemic Chemotherapy In 100 Patients with Multiple Myeloma

Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, Marc-André Weber, Thomas Hielscher, Gerlinde Egerer, Hans-Ulrich Kauczor, Stefan Delorme, Anthony D. Ho, MD, FRCPC, Hartmut Goldschmidt, Kai Neben
Journal: Blood
Blood (2010) 116 (21): 2977.
https://doi.org/10.1182/blood.V116.21.2977.2977
Published: 2010
Journal Articles

Targeting Tissue Factor to Tumor Vessels. Experimental Results and First-in-Man Experience.

Wolfgang E Berdel, MD, Torsten Kessler, MD, Christian Schwöppe, PhD, Ruediger Liersch, MD, Torsten Persigehl, MD, Christoph Bremer, MD, Christoph Schliemann, MD, Rolf Mesters, MD
Journal: Blood
Blood (2009) 114 (22): 469.
https://doi.org/10.1182/blood.V114.22.469.469
Published: 2009
Journal Articles

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathological Microcirculation

Jens Hillengass, Christian M Zechmann, Tobias Bäuerle, Christiane Heiss, Axel Benner, Kai Neben, Anthony D. Ho, MD, PhD, Hartmut Goldschmidt, Stefan Delorme, Thomas M. Moehler
Journal: Blood
Blood (2008) 112 (11): 2704.
https://doi.org/10.1182/blood.V112.11.2704.2704
Published: 2008
Journal Articles

Penetration of Yttrium-90-Labeled Ibritumomab Tiuxetan (Zevalin™) into Primary CNS Lymphoma.

Philipp Kiewe, MD, Agnieszka Korfel, MD, Sofiane Maza, MD, Kristoph Jahnke, MD, Dieter L. Munz, MD, Eckhard Thiel, MD
Journal: Blood
Blood (2006) 108 (11): 2724.
https://doi.org/10.1182/blood.V108.11.2724.2724
Published: 2006
Journal Articles

Dynamic Contrast-Enhanced MRI Identifies a Distinct Group of Asymptomatic Myeloma Patients with Increased Bone Marrow Microcirculation.

Jens Hillengass, MD, Christian Zechmann, MD, Andreas Nadler, Stefan Delorme, MD, Axel Benner, Christiane Heiss, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Thomas Moehler, MD
Journal: Blood
Blood (2006) 108 (11): 5079.
https://doi.org/10.1182/blood.V108.11.5079.5079
Published: 2006
Journal Articles

The Role of Whole-Body Magnetic Resonance Imaging in the Staging and Follow-Up of Bone Disease in Multiple Myeloma.

M. Varettoni, MD, F. Calliada, MD, P. Zappasodi, MD, P. Arcuti, MD, S. Mangiacavalli, MD, C. Rusconi, MD, G. M. Pica, MD, M. Lazzarino, MD, A. Corso, MD
Journal: Blood
Blood (2005) 106 (11): 5063.
https://doi.org/10.1182/blood.V106.11.5063.5063
Published: 2005